Jung‐Hui Sun
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Synthetic Organic Chemistry Methods, Carbohydrate Chemistry and Synthesis, Analytical Chemistry and Chromatography, Cancer Treatment and Pharmacology
Most-Cited Works
- → Possible Role of Valvular Serotonin 5-HT2B Receptors in the Cardiopathy Associated with Fenfluramine(2000)428 cited
- → Discovery of 1-(3‘-Aminobenzisoxazol-5‘-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2‘-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride (Razaxaban), a Highly Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor(2004)188 cited
- → Efficient Synthesis of 5-(Bromomethyl)- and 5-(Aminomethyl)-1-THP-Indazole(1997)127 cited
- → Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase(2014)99 cited
- → Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms(2015)39 cited
- → Beyond U0126. Dianion chemistry leading to the rapid synthesis of a series of potent MEK inhibitors(2004)31 cited
- → A New Synthesis of Aminomalononitrile Tosylate(1980)24 cited
- → Potent, Orally Bioavailable, and Efficacious Macrocyclic Inhibitors of Factor XIa. Discovery of Pyridine-Based Macrocycles Possessing Phenylazole Carboxamide P1 Groups(2019)22 cited
- → The synthesis and antitumor evaluation of unsymmetrical bis-imides(1997)13 cited
- → Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)(2022)9 cited